SINGH SHAWN (CHIEF EXECUTIVE OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/15/2022ACC: 0001415889-22-007688
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
+5K
Net shares
Net buyer
$3.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$0.75
Trade value
$3.74K
% of position
3.4%
6/30/2022
149K→154K
Total
Net shares
+5K
Net value
$3.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2022 | A · Award | +5K | $0.75 | $3.74K | 3.4% | 149K | 154K |
| Total | +5K | $3.74K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned26.23K
Total
26.23K indirect26.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.23K | Indirect |
| Total | 26.23K | 26.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported